News

Pharmabiz8h
Merck inks licence agreement with Teijin Pharma for investigational antibody candidate targeting tau
Merck inks licence agreement with Teijin Pharma for investigational antibody candidate targeting tau: Kenilworth, New Jersey Monday, May 29, 2017, 10:00 Hrs [IST] Merck, known as ...
Pharmabiz10h
CirCode Biomed gets US FDA clearance for IND application of HM2002, the world's first circular RNA drug being administrated in patients
CirCode Biomed gets US FDA clearance for IND application of HM2002, the world's first circular RNA drug being administrated in patients: Shanghai, China Monday, June 2, 2025, 18:0 ...
Pharmabiz11h
DRI seizes 9.72 kg methamphetamine tablets in Mizoram, one person arrested
DRI seizes 9.72 kg methamphetamine tablets in Mizoram, one person arrested: Our Bureau, New Delhi Monday, June 2, 2025, 17:15 Hrs [IST] The Directorate of Revenue Intelligence (DR ...
Pharmabiz11h
AIxMed, Lumea ink partnership to enhance digital pathology platform with AI-powered urine cytology solution
AIxMed, Lumea ink partnership to enhance digital pathology platform with AI-powered urine cytology solution: Santa Clara, California Monday, June 2, 2025, 17:00 Hrs [IST] AIxMed, ...
Pharmabiz11h
Jashubhai H Chaudhari elected as vice-president of PCI
Our Bureau, New Delhi Monday, June 2, 2025, 16:50 Hrs [IST] The Pharmacy Council of India (PCI) announced that Jashubhai Hi ...
Pharmabiz11h
KKR chips in $600 million to Manipal Education and Medical Group to propel growth and expansion
KKR, a leading global investment firm, and Manipal Education and Medical Group (MEMG), a major diversified conglomerate in India for medical education and healthcare announced a $600 million financing ...
Pharmabiz12h
P D Hinduja Hospital and King’s College London collaborate and commence their first training programme for nurses
Our Bureau, Mumbai Monday, June 2, 2025, 16:15 Hrs [IST] ...
Pharmabiz12h
Auron Therapeutics begins patient dosing in phase 1 trial of AUTX-703 in advanced hematologic malignancies
Auron Therapeutics begins patient dosing in phase 1 trial of AUTX-703 in advanced hematologic malignancies: Newton, Massachusetts Monday, June 2, 2025, 16:00 Hrs [IST] Auron Thera ...
Pharmabiz13h
Researchers identify diagnostic aid to determine risk of diabetic foot ulcer recurrence
Researchers identify diagnostic aid to determine risk of diabetic foot ulcer recurrence: Bethesda, Maryland Monday, June 2, 2025, 15:00 Hrs [IST] A research team funded by the Nat ...
Pharmabiz14h
Ministry of Ayush launches portal to address issues of misleading advertisements and ADR
Ministry of Ayush launches portal to address issues of misleading advertisements and ADR: Our Bureau, New Delhi Monday, June 2, 2025, 14:15 Hrs [IST] The Ministry of Ayush has lau ...
Pharmabiz14h
PU Karthikeyan is new director-in-charge of drug control in Tamil Nadu
PU Karthikeyan is new director-in-charge of drug control in Tamil Nadu: Our Bureau, Chennai Monday, June 2, 2025, 14:10 Hrs [IST] PU Karthikeyan, the joint director at the drug co ...
Pharmabiz14h
Merck’s investigational KRAS G12C inhibitor, MK-1084 shows antitumor activity in phase 1 trial
Merck’s investigational KRAS G12C inhibitor, MK-1084 shows antitumor activity in phase 1 trial: Rahway, New Jersey Monday, June 2, 2025, 14:00 Hrs [IST] Merck, known as MSD outs ...